Dr. Zoryana Stoyko, M.D.

Media Releases

Get to know Oncologist Dr. Zoryana Stoyko, who serves patients in New Jersey.

Dr. Stoyko is a seasoned oncologist at Nazha Cancer Center  in Northfield and Galloway, New Jersey. She is also a consulting physician with the Bacharach Institute for Rehabilitation in Pomona, NJ, and attending physician with Shore Medical Center in Somers Point, NJ, and Bacharach Institute for Rehabilitation. While her expertise covers all cancer types and blood disorders, she places a special emphasis on the treatment of breast and gynecologic cancers.

“Nazha Cancer Center is the only cancer care provider in the shore region of southern New Jersey to qualify for membership in the prestigious Sidney Kimmel Cancer Network at Jefferson. Nazha Cancer Center is the premier cancer treatment center in Southern New Jersey’s shore area. The Center specializes in treating and managing many different types of cancer”, states the official website of Nazha Cancer Center. 

Dr. Stoyko received her medical degree in 1991 at Ivano-Frankivsk National Medical University in Ivano-Frankivsk, Ukraine, where she also completed her first internal medicine residency (1991-1993). Upon relocating to the United States, she pursued a second residency in internal medicine at Richmond University Medical Center in Staten Island, New York (2007-2010). She advanced her career with a hematology-oncology fellowship conducted at New York Medical College and Westchester University Medical Center (2010-2013). Dr. Stoyko served as Chief Fellow during her training. She is currently licensed to practice medicine in New Jersey and New York.

Subsequent to her education, Dr. Stoyko attained board certification in internal medicine, medical oncology, and hematology through the American Board of Internal Medicine (ABIM). The American Board of Internal Medicine is a nonprofit, self-appointed physician-evaluation organization that certifies physicians practicing internal medicine and its subspecialties. Dr. Stoyko maintains active professional memberships with the American Society of Clinical Oncology and the American Society of Hematology.

Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices oncology is an oncologist.

Recommended Articles

• Bringing Chronic Lymphocytic Leukemia Patients and Their Doctors Together via Survey

  While patients may entirely admire and respect their doctors, sometimes they simply do not agree with the course of action they are proposing. While this may not be a big deal for a visit about a cold or something minimal, it can be life-altering for those with chronic conditions. That is why a...

• 'Sophie the Brave' Fights Childhood T-Cell Lymphoma

  The story of 2-year-old Sophie Skiles and her arduous battle with T-cell lymphoma pulls at one’s heartstrings while also causing one to marvel at the faith of her Mom, Shelby.The public first learned of Sophie when a newscast about her was posted online October 20, 2017. (KLTB/abc) It soon made it...

• Treatment Options of Multiple Myeloma

  A team led by a consultant haematology specialist takes care of you if you are a multiple myeloma patient. The team discusses your situation and suggests the best treatment for you, but you will finally decide.It may be paramount to compile a list of questions which you will ask the specialist...

• John Quinones Teams Up With Survivors For Leukemia and Lymphoma Society

  Many cancer patients suffer in silence, with the public being largely unaware of the different types of cancer and how they affect patients. Most people obviously know that cancer is well, a bad thing, but there is a lot of nuance and important information that is lost on the common citizen. Most...

• The Promising Future of Gene Therapy and Lymphoma

  Non-Hodgkin lymphoma affects over 700,000 people in America alone. Though current treatments are moderately effective, especially for aggressive forms of the disease, more can be done to help people impacted by NHL. Researchers are doing just that by working to develop new, innovative treatment for...

• New Diagnostic Tool Approved for Lymphoma

  A new diagnostic tool has been approved by the U.S. Food and Drug Administration (FDA) to help researchers identify leukemia and lymphoma cells by using a technique known as flow cytometry. A flow cytometry test for non-Hodgkin’s lymphoma (NHL) can help determine whether normal or abnormal DNA is...